- Home
- NTES vs BMY Comparison
NTES vs BMY Comparison
Compare NTES & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTES
- BMY
- Stock Information
- Founded
- NTES 1997
- BMY 1887
- Country
- NTES China
- BMY United States
- Employees
- NTES N/A
- BMY N/A
- Industry
- NTES Computer Software: Prepackaged Software
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- NTES Technology
- BMY Health Care
- Exchange
- NTES Nasdaq
- BMY Nasdaq
- Market Cap
- NTES 95.1B
- BMY 94.0B
- IPO Year
- NTES 2000
- BMY N/A
- Fundamental
- Price
- NTES $148.26
- BMY $43.59
- Analyst Decision
- NTES Strong Buy
- BMY Hold
- Analyst Count
- NTES 6
- BMY 14
- Target Price
- NTES $129.83
- BMY $57.54
- AVG Volume (30 Days)
- NTES 634.0K
- BMY 18.2M
- Earning Date
- NTES 11-13-2025
- BMY 10-30-2025
- Dividend Yield
- NTES 1.95%
- BMY 5.68%
- EPS Growth
- NTES 19.96
- BMY N/A
- EPS
- NTES 1.49
- BMY 2.49
- Revenue
- NTES $15,310,016,889.00
- BMY $47,704,000,000.00
- Revenue This Year
- NTES $11.57
- BMY N/A
- Revenue Next Year
- NTES $7.58
- BMY N/A
- P/E Ratio
- NTES $19.11
- BMY $17.55
- Revenue Growth
- NTES 2.75
- BMY 2.57
- 52 Week Low
- NTES $75.88
- BMY $42.96
- 52 Week High
- NTES $159.55
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- NTES 50.09
- BMY 39.21
- Support Level
- NTES $145.87
- BMY $43.27
- Resistance Level
- NTES $150.77
- BMY $44.24
- Average True Range (ATR)
- NTES 3.00
- BMY 1.10
- MACD
- NTES -0.93
- BMY -0.08
- Stochastic Oscillator
- NTES 27.48
- BMY 8.86
About NTES NetEase Inc.
Founded in the late 1990s as an internet portal, NetEase has transformed into a leading force in the second-largest online game company gaming in China. While its initial success was built upon the massively multiplayer online role-playing game Fantasy Westward Journey, NetEase has expanded its portfolio with captivating franchises that resonate with both domestic and international players. Over the past decade, the company has created titles such as Justice, Identity V, Naraka: Bladepoint, and Eggy Party, all of which maintain significant player bases today. Beyond in-house development, the company also collaborates with likes of Microsoft and Marvel to create and publish games based on renowned IPs, including World of Warcraft, Diablo Immortal, and Marvel Rivals.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.